Research Peptides
RESEARCH USE ONLY
Research Peptides
RESEARCH USE ONLY
| Ingredients | Survodutide (BI 456906) — GLP-1/glucagon dual receptor agonist peptide, MW about 4.2 kDa |
|---|---|
| Storage | Unopened: store at 2-8°C, protect from light; after first use: can be stored at 2-8°C for 30 days, do not freeze. |
| Shelf life | 24 months |
| SKU | Content - Spec | Pack | Price | Stock |
|---|---|---|---|---|
| SUR10 | 10mg | 10 vials | $269.00 | In stock |
Research reagents are for laboratory and in-vitro research only. Not for human use.
Research reagents are not supplied as medicines and must not be used for diagnosis, treatment, prevention, clinical procedures or self-medication. Product information must not be used as administration or dosing guidance.
For accessories and consumables, follow their own specifications and documented intended use.
Survodutide (abbreviated as SUR) is a GLP-1/glucagon dual receptor agonist used for fat reduction and weight management. It helps reduce body weight by suppressing appetite and promoting energy expenditure.
Suppresses appetite, reduces calorie intake; promotes energy expenditure, accelerates fat breakdown; improves insulin sensitivity, assists blood sugar control; reduces body weight and waist circumference; decreases visceral fat accumulation.
Subcutaneous injection, initial dose of 0.5 mg once weekly, increase every 4 weeks based on tolerance, maximum recommended dose 4.5 mg once weekly; specific dosage regimen should follow doctor's advice.
Obese or overweight adults (BMI ≥30 kg/m² or ≥27 kg/m² with at least one weight-related comorbidity); healthy individuals requiring fat reduction and body shaping (under professional guidance).